Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
Portfolio Pulse from
Aclarion, Inc. (Nasdaq: ACON) is expanding its Nociscan technology access in New York and New Jersey through RadNet affiliates. This expansion aims to enhance the identification of chronic low back pain using biomarkers and AI algorithms.
March 06, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aclarion is expanding its Nociscan technology in New York and New Jersey through RadNet affiliates, potentially increasing its market reach and revenue.
The expansion of Nociscan access in key markets like New York and New Jersey through RadNet affiliates is likely to increase Aclarion's market presence and revenue potential. This strategic move could positively impact Aclarion's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100